Factor B Depleted Sera
Normal human serum depleted of complement Factor B protein.
Product Specifications
| Citations | 8 |
|---|---|
| Description |
Normal human serum depleted of complement Factor B protein. |
| Storage | Store at -70°C or below. Minimize freeze/thaw cycles. |
| Form |
Frozen liquid. 10 mM sodium phosphate, 145 mM NaCl, pH 7.3. No preservative, 0.22 µm filtered. |
| Concentration | >50 mg protein/mL (refer to CoA for lot specific concentration). |
| Applications |
See citations and technical data sheet for application info. |
Ordering Information
| Catalog Number | A506 |
|---|---|
| Catalog Number (CE) | N/A |
| Size | 1.0 mL |
| Price (USD) | $210.00 |
| Price (EURO) | 190,00 € |
Contact us
| US Phone | +1 (858) 552 1100 |
|---|---|
| EU Phone | +353 (91) 412 474 |
| US Email | contact-us@quidelortho.com |
| EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
| Description |
Normal human serum depleted of complement Factor B protein. |
|---|---|
| Size | 1.0 mL |
| Storage |
Store at -70°C or below. Minimize freeze/thaw cycles. |
| Form | Frozen liquid. 10 mM sodium phosphate, 145 mM NaCl, pH 7.3. No preservative, 0.22 µm filtered. |
| Concentration | >50 mg protein/mL (refer to CoA for lot specific concentration). |
| Applications | See citations and technical data sheet for application info. |
| Purity | No Factor B detectable by immunodiffusion. |
| Source |
Normal human serum |
| Activity | >80% versus normal human serum standard. |
| Molecular Weight | N/A |
| Background |
Normal human serum depleted of factor B by immunoaffinity chromatography. The product is tested for the absence of factor B by functional assays for alternative pathway activity and for factor B protein by double immunodiffusion. |
Citations
| Title | Year | Applications | Sample Species | Sample | Sample Details |
|---|---|---|---|---|---|
| 2015 | Complement Activation Assay |
Cell Culture |
CHO Cells |
||
| 2014 | IF |
Cell Culture |
TIME-KSHV cells |
||
|
EGFR modulates complement activation in head and neck squamous cell carcinoma. |
2020 | IF |
Cell Culture |
HNSCC Cells |
|
|
Complement activation by bisretinoid constituents of RPE lipofuscin. |
2009 | ELISA |
Human |
Serum |
|
| 2014 | ELISA |
Human |
Serum |
||
|
Extracellular vesicles from KSHV-infected endothelial cells activate the complement system |
2017 | ELISA |
Human |
HUVEC Cells |
KSHV infection |
| 2013 | FC |
Human |
Serum |
Staphylococcus epidermidis incubated |
|
| 2014 | Serum Bactericidal Assay |
Human |
Serum |
Burkholderia cenocepacia incubated |
Certificate of Analysis
